Neuren is also investigating the effects of NNZ-2591 in models of other neurodevelopmental disorders, with a view to initiating clinical trials in more than one indication.
So PhMS and...? Could Multiple Sclerosis be described as neurodevelopmental? I'm thinking no...
Anyway, another news point at some stage: the plus one.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.83 |
Change
-0.130(1.00%) |
Mkt cap ! $1.594B | |||
| Open | High | Low | Value | Volume |
| $12.82 | $13.05 | $12.53 | $5.809M | 453.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 240 | $13.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.52 | 3 | 1 |
View Market Depth
| Last trade - 15.59pm 17/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |